Importantly, we also evaluate the landscape of candidate ferroptosis-related biomarkers, which are indispensable for clinical translation, and discuss the major challenges that must be addressed to advance ferroptosis-targeted interventions from preclinical models to patient care
10.7150/ijms.98246 58 KasprzykP
MOTS-c vs NAD+: Where Each One Is Stronger MOTS-c is stronger for metabolic dysfunction and body composition If the patients primary complaints are insulin resistance, difficulty losing visceral fat despite consistent effort, or body composition that has stopped responding to diet and training, MOTS-c is the more targeted tool
It helps cells travel to where theyre needed and supports recovery across multiple areas at once
In experimental models of inflammatory bowel disease and intestinal injury, the peptide consistently improves mucosal integrity, reduces local and systemic inflammatory mediators, and counters damage induced by stressors such as NSAIDs, alcohol, and other toxic agents
M.KaarnirantaK
